Chun Shin Foo1, Chacko Jobichen2, Varuna Hassan-Puttaswamy1, Zoltan Dekan3, Han-Shen Tae4, Daniel Bertrand5, David J Adams4, Paul F Alewood3, J Sivaraman2, Selvanayagam Nirthanan6, R Manjunatha Kini1. 1. Protein Science Laboratory, Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Singapore. 2. Department of Biological Sciences, National University of Singapore, Singapore. 3. Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia. 4. Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia. 5. HiQScreen Sàrl, Geneva, Switzerland. 6. School of Medical Science, Griffith Health Group, Griffith University, Gold Coast, Queensland, Australia.
Abstract
BACKGROUND AND PURPOSE: Animal toxins have contributed significantly to our understanding of the neurobiology of receptors and ion channels. We studied the venom of the coral snake Micrurus fulvius fulvius and identified and characterized the structure and pharmacology of a new homodimeric neurotoxin, fulditoxin, that exhibited novel pharmacology at nicotinic ACh receptors (nAChRs). EXPERIMENTAL APPROACH: Fulditoxin was isolated by chromatography, chemically synthesized, its structure determined by X-ray crystallography, and its pharmacological actions on nAChRs characterized by organ bath assays and two-electrode voltage clamp electrophysiology. KEY RESULTS: Fulditoxin's distinct 1.95-Å quaternary structure revealed two short-chain three-finger α-neurotoxins (α-3FNTxs) non-covalently bound by hydrophobic interactions and an ability to bind metal and form tetrameric complexes, not reported previously for three-finger proteins. Although fulditoxin lacked all conserved amino acids canonically important for inhibiting nAChRs, it produced postsynaptic neuromuscular blockade of chick muscle at nanomolar concentrations, comparable to the prototypical α-bungarotoxin. This neuromuscular blockade was completely reversible, which is unusual for snake α-3FNTxs. Fulditoxin, therefore, interacts with nAChRs by utilizing a different pharmacophore. Unlike short-chain α-3FNTxs that bind only to muscle nAChRs, fulditoxin utilizes dimerization to expand its pharmacological targets to include human neuronal α4β2, α7, and α3β2 nAChRs which it blocked with IC50 values of 1.8, 7, and 12 μM respectively. CONCLUSIONS AND IMPLICATIONS: Based on its distinct quaternary structure and unusual pharmacology, we named this new class of dimeric Micrurus neurotoxins represented by fulditoxin as Σ-neurotoxins, which offers greater insight into understanding the interactions between nAChRs and peptide antagonists.
BACKGROUND AND PURPOSE: Animal toxins have contributed significantly to our understanding of the neurobiology of receptors and ion channels. We studied the venom of the coral snake Micrurus fulvius fulvius and identified and characterized the structure and pharmacology of a new homodimeric neurotoxin, fulditoxin, that exhibited novel pharmacology at nicotinic ACh receptors (nAChRs). EXPERIMENTAL APPROACH: Fulditoxin was isolated by chromatography, chemically synthesized, its structure determined by X-ray crystallography, and its pharmacological actions on nAChRs characterized by organ bath assays and two-electrode voltage clamp electrophysiology. KEY RESULTS: Fulditoxin's distinct 1.95-Å quaternary structure revealed two short-chain three-finger α-neurotoxins (α-3FNTxs) non-covalently bound by hydrophobic interactions and an ability to bind metal and form tetrameric complexes, not reported previously for three-finger proteins. Although fulditoxin lacked all conserved amino acids canonically important for inhibiting nAChRs, it produced postsynaptic neuromuscular blockade of chick muscle at nanomolar concentrations, comparable to the prototypical α-bungarotoxin. This neuromuscular blockade was completely reversible, which is unusual for snake α-3FNTxs. Fulditoxin, therefore, interacts with nAChRs by utilizing a different pharmacophore. Unlike short-chain α-3FNTxs that bind only to muscle nAChRs, fulditoxin utilizes dimerization to expand its pharmacological targets to include human neuronal α4β2, α7, and α3β2 nAChRs which it blocked with IC50 values of 1.8, 7, and 12 μM respectively. CONCLUSIONS AND IMPLICATIONS: Based on its distinct quaternary structure and unusual pharmacology, we named this new class of dimeric Micrurus neurotoxins represented by fulditoxin as Σ-neurotoxins, which offers greater insight into understanding the interactions between nAChRs and peptide antagonists.
Authors: Carlos Corrêa-Netto; Inácio de L M Junqueira-de-Azevedo; Débora A Silva; Paulo L Ho; Moema Leitão-de-Araújo; Maria Lúcia M Alves; Libia Sanz; Débora Foguel; Russolina Benedeta Zingali; Juan J Calvete Journal: J Proteomics Date: 2011-04-12 Impact factor: 4.044
Authors: Peter H Zwart; Pavel V Afonine; Ralf W Grosse-Kunstleve; Li-Wei Hung; Thomas R Ioerger; Airlie J McCoy; Erik McKee; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Laurent C Storoni; Thomas C Terwilliger; Paul D Adams Journal: Methods Mol Biol Date: 2008
Authors: Alexey V Osipov; Igor E Kasheverov; Yana V Makarova; Vladislav G Starkov; Olga V Vorontsova; Rustam Kh Ziganshin; Tatyana V Andreeva; Marina V Serebryakova; Audrey Benoit; Ronald C Hogg; Daniel Bertrand; Victor I Tsetlin; Yuri N Utkin Journal: J Biol Chem Date: 2008-04-01 Impact factor: 5.157
Authors: Stephen P H Alexander; Alistair Mathie; John A Peters; Emma L Veale; Jörg Striessnig; Eamonn Kelly; Jane F Armstrong; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2019-12 Impact factor: 8.739